GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GlaxoSmithKline (GSK) UK healthcare professional website search results.
dolutegravir/abacavir/lamivudine <br>HIV
Patients who are not recommended to receive BENLYSTA once-weekly subcutaneous injection, use in pregnancy and lactation.
BENLYSTA once-weekly subcutaneous injection, safety
Storage and disposal instruction for BENLYSTA Pre-filled Pen for once-weekly subcutaneous injection
Administration of BENLYSTA once-weekly subcutaneous injection
Effect of BENLYSTA once-weekly subcutaneous injection on disease activity reduction in patients with high disease activity
BENLYSTA selectively inhibits BLyS, an important factor in SLE
BENLYSTA once-weekly subcutaneous injection – Significant improvement in fatigue
BENLYSTA once-weekly subcutaneous injection – reduction in corticosteroid use
Overview of BLISS-SC clinical trial
Description of SLE Responder Index and its components
Overview of key efficacy points of BENLYSTA once-weekly subcutaneous injection
Detailed description of a patient with lupus and chronic fatigue presentation, including manifestation and laboratory assessment.
Detailed description of a patient with mucocutaneous and musculoskeletal lupus, including clinical manifestation and laboratory assessment.
Detailed description of a patient with mucocutaneous and musculoskeletal lupus, including clinical manifestation and laboratory assessment.
Characteristics of patients eligible for BELYSTA once-weekly subcutaneous injection, high disease activity characteristics, clinical manifestations, concomitant medications
Belimumab <br> Systemic Lupus Erythematous
Meningococcal Group B Vaccine (rDNA, component, absorbed) <br> Vaccines
dolutegravir/lamivudine</br> HIV
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
Exacerbation efficacy results for TRELEGY Ellipta.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
Relvar Ellipta summary of efficacy in asthma – including the latest data on efficacy against symptoms and exacerbations, improvements in Quality of Life and lung function
Relvar▼ Ellipta 92/22 mcg summary of efficacy in COPD – including the latest data on efficacy, exacerbations, improvements in lung function and COPD-related health status
Find out about Trelegy Ellipta’s mode of action in asthma patients
fluticasone furoate/umeclidinium/vilanterol <br>Respiratory
Ambrisentan<br>Pulmonology
bupropion hydrochloride<br>Psychiatry
cefuroxime axetil<br>Anti-infectives
amoxicillin-clavulanate<br>Anti-infectives
fluticasone furoate<br>Respiratory
0.5 mg Dutasteride and 0.4 mg Tamsulosin hydrochloride<br>Urology
salmeterol xinafoate / fluticasone propionate<br>Respiratory
Umeclidinium <br>Respiratory
SHINGRIX prescribing information for UK healthcare professionals
SHINGRIX prescribing information for UK healthcare professionals
SHINGRIX prescribing information for UK healthcare professionals
SHINGRIX prescribing information for UK healthcare professionals
SHINGRIX prescribing information for UK healthcare professionals
SHINGRIX prescribing information for UK healthcare professionals
Shingrix ▼ efficacy and safety data in immunocompromised patients for UK healthcare professionals
shingles burden of disease information for UK healthcare professionals
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
fluticasone furoate / vilanterol <br>Respiratory
Discover the efficacy of Trelegy in reducing exacerbations
Find out about Trelegy Ellipta’s efficacy data in asthma patients
Discover Trelegy Ellipta dosing and device information for asthma patients
mepolizumab<br> Respiratory
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
A page on Trelegy Ellipta Webinar - 2022
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
umeclidinium/vilanterol<br> Respiratory
Discover how to use Trelegy Ellipta to treat patients with asthma
Lung Function efficacy results for TRELEGY Ellipta
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
Trelegy Ellipta is a Triple Therapy for appropriate patients with COPD.
Page providing information about Quality of Life for Trelegy fulfill study.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
Trelegy Ellipta in COPD and ASTHMA
Health-related QoL efficacy results for TRELEGY Ellipta
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
Find how to identify asthma patients appropriate for treatment with Trelegy Ellipta
Learn about Trelegy Ellipta’s safety profile for asthma patients